SCHEMBL8107627

SCHEMBL8107627

ON=C1CCN(Cc2ccccc2Cl)CC1.ON=C1CCN(Cc2ccccc2Cl)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.58
CYP2A13 Q16696 2/20 0.57
ALDH1A1 P00352 7/20 0.55
KDM4E B2RXH2 5/20 0.55
PLA2G1B P04054 1/20 0.55
RAB9A P51151 1/20 0.55
ATG4B Q9Y4P1 1/20 0.55
HTT P42858 1/20 0.54
CXCR4 P61073 3/20 0.53
GAA P10253 2/20 0.51
MAPT P10636 2/20 0.51
LMNA P02545 2/20 0.50
USP2 O75604 1/20 0.50
ABCB11 O95342 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
ADRA2A P08913 1/20 0.50
ADORA3 P0DMS8 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6946174 1.00 SIGMAR1 (0.58) SIGMAR1CYP2A13ALDH1A1KDM4EPLA2G1B
SCHEMBL6941394 0.82 CYP2A13 (0.56) CYP2A13ALDH1A1KDM4ERAB9ACXCR4
SCHEMBL11360607 0.80 SIGMAR1 (0.85) SIGMAR1CYP2A13ALDH1A1KDM4EPLA2G1B
SCHEMBL7270268 0.80 SIGMAR1 (0.61) SIGMAR1KDM4EGAAMAPTLMNA
SCHEMBL5675319 0.78 SIGMAR1 (0.64) SIGMAR1CYP2A13ALDH1A1KDM4EPLA2G1B
SCHEMBL8108285 0.78 SIGMAR1 (0.64) SIGMAR1CYP2A13ALDH1A1KDM4EPLA2G1B
SCHEMBL23851311 0.77 SIGMAR1 (0.72) SIGMAR1CYP2A13ALDH1A1KDM4EPLA2G1B
SCHEMBL9417737 0.77 SIGMAR1 (0.72) SIGMAR1CYP2A13ALDH1A1KDM4EPLA2G1B
Hydrochloric Acid SCHEMBL11467058 0.75 SIGMAR1 (0.70) SIGMAR1CYP2A13ALDH1A1KDM4EPLA2G1B
SCHEMBL5738303 0.75 ALDH1A1 (0.73) SIGMAR1CYP2A13ALDH1A1KDM4EPLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056744-A1 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES Aventis Pharmaceuticals Inc. (US) 2000-12-06 EP disclosed
WO-1999043675-A1 6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMACEUTICALS INC. (US) 1999-09-02 WO disclosed